Current therapy of chronic hepatitis B.
Pardo
Margarita
M
Fundación para el Estudio de las Hepatitis Virales, Madrid, Spain.
Bartolomé
Javier
J
Carreño
Vicente
V
D000998:Antiviral Agents / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D015316:Genetic Therapy; D017325:Hepatitis B Vaccines / Q000627:therapeutic use*; D006515:Hepatitis B virus / Q000187:drug effects / Q000502:physiology; D019694:Hepatitis B, Chronic / Q000276:immunology / Q000378:metabolism / Q000628:therapy* / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000276:immunology / Q000627:therapeutic use; D008222:Lymphokines / Q000276:immunology / Q000627:therapeutic use; D019384:Nucleic Acid Synthesis Inhibitors / Q000378:metabolism / Q000627:therapeutic use; D019444:Vaccines, DNA / Q000276:immunology / Q000627:therapeutic use*
D000998:Antiviral Agents; D017325:Hepatitis B Vaccines; D016898:Interferon-alpha; D008222:Lymphokines; D019384:Nucleic Acid Synthesis Inhibitors; D019444:Vaccines, DNA